Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review
Ana Y. Simão, Joana Gonçalves, Ana Paula Duarte, Mário Barroso, Ana Clara Cristóvão, Eugenia Gallardo
Medicines October 18, 2019 DOI: 10.3390/medicines6040106 via OpenAlex
Summary
AI-generated from the abstractAyahuasca, a psychoactive beverage traditionally used by indigenous Amazonian tribes for ritual and medicinal purposes, contains compounds such as N,N-dimethyltryptamine (DMT), β-Carbolines, and harmala alkaloids including harmine, tetrahydroharmine, and harmaline. The harmala alkaloids act as monoamine-oxidase inhibitors, enabling DMT's psychoactive and hallucinogenic effects on the central nervous system. Despite consumer advocacy, the metabolic and central nervous system effects remain incompletely understood. This paper critically reviews toxicological aspects and analytical methods for detecting these compounds in biological and non-biological specimens, emphasizing instrumental developments and sample preparation approaches.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Ayahuasca |
| Keywords | Harmine Harmaline Hallucinogen Traditional medicine |
| Citations | 36 |
| Key finding | The paper provides a comprehensive and critical review of the toxicological aspects and analytical methods for determining ayahuasca compounds in biological and non-biological specimens. |
Abstract
Ayahuasca is a psychoactive beverage prepared traditionally from a mixture of the leaves and stems of Psychotria viridis and Banisteriopsis caapi, respectively, being originally consumed by indigenous Amazonian tribes for ritual and medicinal purposes. Over the years, its use has spread to other populations as a means to personal growth and spiritual connection. Also, the recreational use of its isolated compounds has become prominent. The main compounds of this tea-like preparation are N,N-dimethyltryptamine (DMT), β-Carbolines, and harmala alkaloids, such as harmine, tetrahydroharmine, and harmaline. The latter are monoamine-oxidase inhibitors and are responsible for DMT psychoactive and hallucinogenic effects on the central nervous system. Although consumers defend its use, its metabolic effects and those on the central nervous system are not fully understood yet. The majority of studies regarding the effects of this beverage and of its individual compounds are based on in vivo experiments, clinical trials, and even surveys. This paper will not only address the toxicological aspects of the ayahuasca compounds but also perform a comprehensive and critical review on the analytical methods available for their determination in biological and non-biological specimens, with special focus on instrumental developments and sample preparation approaches.